| 摘要 |
<p>The present invention is characterised by certain genetic variants being susceptibility variants for prostate cancer. The invention relates to methods of determining increased susceptibility to prostate cancer, as well as methods of determining decreased susceptibility to prostate cancer, using such variants. The invention further relates to apparatus for determining a genetic indicator for prostate cancer in a human individual, and the use of an oligonucleotide probe in the manufacture of a reagent for diagnosing and/or assessing susceptibility to prostate cancer in a human individual.</p> |
